期刊文献+

Wip1基因沉默对结肠癌细胞化疗敏感性的影响 被引量:5

Effect of Wip1 gene silencing on chemotherapy sensitivity of human colon cancer cells
下载PDF
导出
摘要 目的:观察靶向Wip1基因的特异性siRNA序列对结肠癌细胞Wip1基因的抑制效应,探讨Wip1基因沉默对结肠癌细胞化疗敏感性的影响。方法:将Wip1-811 siRNA转染入Wip1高表达的RKO结肠癌细胞株,采用real-time PCR法检测Wip1 mRNA的表达,采用Western blotting方法检测Wip1蛋白表达,采用MTS方法检测结肠癌细胞活力,流式细胞术检测细胞凋亡及细胞周期。结果:Wip1-811 siRNA明显抑制Wip1的表达。抑制Wip1基因表达后,转染组RKO结肠癌细胞对抗肿瘤药物的敏感性增加,5-氟尿嘧啶处理组RKO结肠癌细胞活力由(89.4±6.6)%降至(74.7±3.9)%(P<0.05),奥沙利铂处理组细胞活力由(77.9±2.4)%降至(66.7±2.9)%(P<0.05)。转染Wip1-811 siRNA后,5-氟尿嘧啶处理组细胞凋亡比例由(7.7±0.5)%升至(12.3±3.2)%(P<0.05);奥沙利铂处理组细胞凋亡比例由(14.7±2.1)%升至(34.0±2.1)%(P<0.05)。结论:沉默Wip1基因表达能增强结肠癌细胞的化疗敏感性。 AIM:To observe the inhibitory effect of siRNA targeting to Wip1 gene on the Wip1 gene expression in the colon cancer cells and to investigate the influence of Wip1 gene silencing on the chemotherapy sensitivity of colon cancer cells.METHODS:Wip1-811 siRNA targeting to Wip1 gene was transfected into RKO colon cancer cells with high expression of Wip1 gene.The mRNA expression of Wip1 was measured by real-time PCR.The protein level of Wip1 was detected by Western blotting.The viability of RKO colon cancer cells was measured by MTS assay.The cell apoptosis and cell cycle were analyzed by flow cytometry.RESULTS: Wip1-811 siRNA efficiently inhibited the expression of Wip1 at mRNA and protein levels.The enhanced chemotherapy sensitivity of RKO colon cancer cells was observed after inhibition of Wip1 gene expression.The viability of RKO colon cancer cells was decreased from (89.4 ±6.6)%to (74.7 ±3.9)%af-ter treated with 5-fluorouracil (P〈0.05) and decreased from (77.9 ±2.4)%to (66.7 ±2.9)%after treated with oxali-platin ( P〈0.05 ) .The cell apoptotic rate was increased from ( 7.7 ±0.5 )% to ( 12.3 ±3.2 )% and from ( 14.7 ± 2.1)% to (34.0 ±2.1)% when RKO colon cancer cells were treated with 5-fluorouracil and oxaliplatin, respectively (P〈0.05).CONCLUSION:Wip1 gene silencing enhances chemotherapy sensitivity of colon cancer cells.
出处 《中国病理生理杂志》 CAS CSCD 北大核心 2015年第5期857-863,共7页 Chinese Journal of Pathophysiology
关键词 结肠癌 小干扰RNA Wip1基因 化疗敏感性 Colon cancer Small interfering RNA Wip1 gene Chemotherapy sensitivity
  • 相关文献

参考文献10

  • 1夏忠胜,朱兆华,陈其奎,钟荚强,张立勇,刘仲敏,ADAM Bao-ling.靶向MDR1基因的RNAi稳定逆转结肠癌细胞的多药耐药性[J].中国病理生理杂志,2009,25(5):898-903. 被引量:13
  • 2Zhang C, Chen Y, Wang M, et al. PPM1D silencing by RNA interference inhibits the proliferation of lung cancer cells[J]. World J Surg Oneol, 2014, 12: 258.
  • 3Donehower LA. Phosphatases reverse p53-mediated cell cycle checkpoints[J]. Proc Natl Acad Sci U S A, 2014, 111(20) :7172-7173.
  • 4Yang D, Zhang H, Hu X, et al. Abnormality of p16/ p38MAPK/p53/Wipl pathway in papillary thyroid cancer [J3. Gland Surg, 2012, 1(1) :33-38.
  • 5Li ZT, Zhang L, Gao XZ, et al. Expression and signifi- cance of the Wipl proto-oncogene in colorectal cancer[ J]. Asian Pac J Cancer Prev, 2013, 14(3) : 1975-1979.
  • 6Nopel-Dtinnebacke S, Schulmann K, Reinacher-Schick A, et al. Prognostic value of microsatellite instability and p53 expression in metastatic colorectal cancer treated with oxaliplatin and fluoropyrimidine-based chemotherapy [ J ]. Z Gastroenterol, 2014, 52 (12) : 1394-1401.
  • 7Bisteau X, Caldez M J, Kaldis P. The complex relation- ship between liver cancer and the cell cycle: a story of multiple regulations[J]. Cancers (Basel), 2014, 6(1): 79-111.
  • 8Yu E, Ahn YS, Jang SJ, et al. Overexpression of the wipl gene abrogates the p38 MAPK/p53/Wipl pathway and silences p16 expression in human breast cancers[J]. Breast Cancer Res Treat, 2007, 101 (3) :269-278.
  • 9Brazina J, Svadlenka J, Macurek L, et al. DNA damage- induced regulatory interplay between DAXX, p53, ATM kinase and Wipl phosphatase [ J ]. Cell Cycle, 2015, 14 (3) :375-387.
  • 10Zhang XL, Wan G, Mlotshwa S, et al. Oncogenic Wipl phosphatase is inhibited by miR-16 in the DNA damage signaling pathway [ J ]. Cancer Res, 2010, 70 ( 18 ) : 7176- 7186.

二级参考文献11

  • 1张晓菁,温泽清,张华玲,石敏.RNA干扰技术抑制耐药细胞MDR1基因表达的研究[J].中国病理生理杂志,2006,22(5):833-836. 被引量:10
  • 2Germann UA, Pastan I, Gottesman MM. P - glycoproteins: mediators of multidrug resistance [ J ]. Semin Cell Biol, 1993, 4(1) : 63 -76.
  • 3Li J, Xu LZ, He L, et al. Reversal effects of nomegestrol acetate on multidrug resistance in adriamycin - resistant MCF7 breast cancer cell line [ J ]. Breast Cancer Res, 2001, 3(4) : 253 -263.
  • 4Borst P, Evers R, Kool M, et al. A family of drug transporters : the muhidrug resistance - associated proteins [ J ]. J Natl Cancer Inst, 2000, 92(16) : 1295 -1302.
  • 5Lage H, Dietel M. Effect of the breast - cancer resistance protein on atypical multidrug resistance [ J ]. Lancet Oncol, 2000, 1 ( 1 ) : 169 - 175.
  • 6Nieth C, Priebsch A, Stege A, et al. Modulation of the classical multidrug resistance (MDR) phenotype by RNA interference (RNAi) [ J ]. FEBS Lett, 2003, 545 (2 - 3) : 144 - 150.
  • 7Klimecki WT, Futscher BW, Grogan TM, et al. P- glycoprotein expression and function in circulating blood cells from normal volunteers[J]. Blood, 1994, 83(9): 2451 - 2458.
  • 8Licht T, Pastan I, Gottesman M, et al. P- glycoprotein- mediated multidrug resistance in normal and neoplastic hematopoietic cells[ J]. Ann Hematol, 1994, 69(4) :159 -171.
  • 9van der Valk P, van Kalken CK, Ketelaars H, et al. Distribution of muhidrug resistance - associated P - glycoprotein in normal and neoplastic human tissues. Analysis with 3 monoclonal antibodies recognizing different epitopes of the P - glycoprotein molecule [ J ]. Ann Oncol, 1990, 1 (1) : 56 -64.
  • 10Smeets M, Raymakers R, Vierwinden G, et al. A low but functionally significant MDR1 expression protects primitive haemopoietic progenitor cells from anthracycline toxicity [J]. Br J Haematol, 1997, 96(2) : 346 -355.

共引文献12

同被引文献29

  • 1ZHU Y H,BULAVIN D V.Wip1-dependent signaling pathways in health and diseases[J].Prog Mol Biol Transl Sci,2012,106:307-325.
  • 2MEEK D W.Regulation of the p53response and its relationship to cancer[J].Biochem J,2015,469:325-346.
  • 3BULAVIN D V,DEMIDOV ON,SAITO S,et al.Amplification of PPM1Din human tumors abrogates p53tumor-suppressor activity[J].Nat Genet,2002,31:210-215.
  • 4LOWE J,CHA H,LEE M O,et al.Regulation of the Wip1phosphatase and its effects on the stress response[J].Front Biosci,2012,17:1480-1498.
  • 5YANG D H,HE J A,LI J,et al.Expression of protooncogene Wip1in breast cancer and its clinical significance[J].Zhong Hua Yi Xue Za Zhi,2010,90:519-522.
  • 6LIU S,QI L,HAN W,et al.Overexpression of wip1is associated with biologic behavior in human clear cell renal cell carcinoma[J].PLoS One,2014,9:e110218-e110218.
  • 7FU Z,SUN G,GU T.Proto-oncogene Wip1,a member of a new family of proliferative genes in NSCLC and its clinical significance[J].Tumour Biol,2014,35:2975-2981.
  • 8SUN G G,ZHANG J,MA X B.Overexpression of Wild-Type p53-Induced Phosphatase 1 Confers Poor Prognosis of Patients with Nasopharyngeal Carcinoma[J].Pathol Oncol Res,2015,21:283-291.
  • 9ZHANG Y,SUN H,HE G,et al.WIP1regulates the proliferation and invasion of nasopharyngeal carcinoma in vitro[J].Tumour Biol,2014,35:7651-7657.
  • 10TANG Y L,LIU X,GAO S Y,et al.WIP1stimulates migration and invasion of salivary adenoid cystic carcinoma by inducing MMP-9and VEGF-C[J].Oncotarget,2015,6:9031-9044.

引证文献5

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部